BCM(R) MRSA 1.0 BASAL MEDIUM | BCM(R) MRSA 1.0 BASAL MEDIUM | |
BcnI (CauII) | BcnI (CauII) | |
BCM(R) O157:H7(+) | BCM(R) O157:H7(+) | |
BD 1047 DIHYDROBROMIDE | BD 1047 DIHYDROBROMIDE | 138356-20-4 |
BD 1008 Dihydrobromide | BD 1008 Dihydrobromide | 138356-09-9 |
BCM(R) SHIGELLA 1.0 PLATING MEDIUM | BCM(R) SHIGELLA 1.0 PLATING MEDIUM | |
BDCS, silylation reagent, AcroSeal | BDCS, silylation reagent, AcroSeal | 1185092-02-7 |
7b-deacetyl-7b-(gamma-(morpholino)butyryl)forskolin | 7b-deacetyl-7b-(gamma-(morpholino)butyryl)forskolin | |
B-decachloro-1,2-dicarbadecaborane | B-decachloro-1,2-dicarbadecaborane | 18988-74-4 |
B-DECALACTONE | B-DECALACTONE | |
1,2,3,4,6,7,8,9,10,10b-Decahydro-6,6-dimethylcyclopenta[a]quinolizine | 1,2,3,4,6,7,8,9,10,10b-Decahydro-6,6-dimethylcyclopenta[a]quinolizine | 73825-74-8 |
1,2,3,4,6,7,8,11,12,12b-Decahydrobenz[a]anthracene | 1,2,3,4,6,7,8,11,12,12b-Decahydrobenz[a]anthracene | 16434-56-3 |
1,3,4,6,7,8,9,10,11,11b-Decahydro-6,6-dimethyl-2H-benzo[a]quinolizine | 1,3,4,6,7,8,9,10,11,11b-Decahydro-6,6-dimethyl-2H-benzo[a]quinolizine | 73713-73-2 |
BCMV protocol | BCMV protocol | |
B834(DE3) COMPETENT CELLS | B834(DE3) COMPETENT CELLS | |
BBXNEFA | BBXNEFA | |
B834(DE3) COMP CELLS* | B834(DE3) COMP CELLS* | |
b-Defensin-4, human | b-Defensin-4, human | |
b-Defensin-1, human | b-Defensin-1, human | |
b-Defensin-3, human | b-Defensin-3, human | |
B834(DE3) GLYCEROL STOCK* | B834(DE3) GLYCEROL STOCK* | |
BBXS | BBXS | |
1-BCP | 1-BCP | 34023-62-6 |
BDF-8784 | BDF-8784 | 133408-47-6 |
BDE 209 in 2,2,4-Trimethylpentane | BDE 209 in 2,2,4-Trimethylpentane | |
BD FACS LYSING SOLUTION | BD FACS LYSING SOLUTION | |
BCNU, [CHLOROETHYL-2-14C]- 45-60 MCI(1.67-2.22 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 98 PURE WITH HPLC RADIOCHROMATOGRAM | BCNU, [CHLOROETHYL-2-14C]- 45-60 MCI(1.67-2.22 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 98% PURE WITH HPLC RADIOCHROMATOGRAM | |
BD FACS RINSE | BD FACS RINSE | |
BD FACS CLEAN | BD FACS CLEAN | |
BD FACS PERMEABILIZING SOLUTION 2 | BD FACS PERMEABILIZING SOLUTION 2 | |
BCNT protein | BCNT protein | |
BD FASTIMMUNE CD8/CD69/CD3 | BD FASTIMMUNE CD8/CD69/CD3 | |
BD FASTIMMUNE ANTI-IFN-GAMMA/ANTI-IL-4 | BD FASTIMMUNE ANTI-IFN-GAMMA/ANTI-IL-4 | |
BD FASTIMMUNE ANTI-TNF-ALPHA/CD69/CD4 | BD FASTIMMUNE ANTI-TNF-ALPHA/CD69/CD4 | |
BD FASTIMMUNE CD69/CD3 | BD FASTIMMUNE CD69/CD3 | |
BD FASTIMMUNE GAMMA2A/GAMMA1/CD4 ISOTYPE CONTROL | BD FASTIMMUNE GAMMA2A/GAMMA1/CD4 ISOTYPE CONTROL | |
BD FASTIMMUNE GAMMA2A/GAMMA1 ISOTYPE CONTROL, FITC, PE | BD FASTIMMUNE GAMMA2A/GAMMA1 ISOTYPE CONTROL, FITC, PE | |
BD FASTIMMUNE GAMMA1/CD45 ISOTYPE CONTROL | BD FASTIMMUNE GAMMA1/CD45 ISOTYPE CONTROL | |
BD FASTIMMUNE GAMMA2A/GAMMA1/CD8/CD3 | BD FASTIMMUNE GAMMA2A/GAMMA1/CD8/CD3 | |
BD FASTIMMUNE ANTI-IL-2/CD69/CD4 | BD FASTIMMUNE ANTI-IL-2/CD69/CD4 | |
BD FASTIMMUNE ANTI-IFN-GAMMA/CD69/CD4 | BD FASTIMMUNE ANTI-IFN-GAMMA/CD69/CD4 | |
BD FASTIMMUNE CD63/CD123/ANTI-HLA-DR | BD FASTIMMUNE CD63/CD123/ANTI-HLA-DR | |
BD FASTIMMUNE CD56/CD69/CD45 | BD FASTIMMUNE CD56/CD69/CD45 | |
BD FASTIMMUNE GAMMA1/GAMMA1/CD3 ISOTYPE CONTROL | BD FASTIMMUNE GAMMA1/GAMMA1/CD3 ISOTYPE CONTROL | |
BD FASTIMMUNE CD2/CD2R | BD FASTIMMUNE CD2/CD2R | |
BD FASTIMMUNE CD4/CD69/CD3 | BD FASTIMMUNE CD4/CD69/CD3 | |
BD FASTIMMUNE CD19/CD69/CD45 | BD FASTIMMUNE CD19/CD69/CD45 | |
BD FASTIMMUNE GAMMA1/CD3 ISOTYPE CONTROL | BD FASTIMMUNE GAMMA1/CD3 ISOTYPE CONTROL | |
BDELLIN | BDELLIN | 62494-89-7 |
bdellastasin | bdellastasin | |
BCPC 1-benzyl-3-carboxyl pyridinium chloride | BCPC 1-benzyl-3-carboxyl pyridinium chloride | |
B27 COM, FLUORESCEIN, FITC CONJUGATE | B27 COM, FLUORESCEIN, FITC CONJUGATE | |
BCOMM protocol | BCOMM protocol | |
B.C.P.-Deoxycholate Agar
| B.C.P.-Deoxycholate Agar
| |
2B/3, Dengue Protease Substrate
| 2B/3, Dengue Protease Substrate
| |
BCPE protocol | BCPE protocol | |
B834(DE3)pLysS GLYCEROL STOCK* | B834(DE3)pLysS GLYCEROL STOCK* | |
B834(DE3)pLysS CC* | B834(DE3)pLysS CC* | |
B834(DE3)PLYSS COMPETENT CELLS | B834(DE3)PLYSS COMPETENT CELLS | |
B-CORE-APE-HSA | B-CORE-APE-HSA | |
B-CORE-APE-HSA,GALA1-3GALSS1-O-APE-HSA | B-CORE-APE-HSA,GALA1-3GALSS1-O-APE-HSA | |
BDG | BDG | |
BCoR protein | BCoR protein | |
BCPI-1 protein | BCPI-1 protein | |
b-D-Galactopyranoside, phenyl 2,3-bis-O-(phenylMethyl)-4,6-O-[(S)-phenylMethylene]-1-thio- | b-D-Galactopyranoside, phenyl 2,3-bis-O-(phenylMethyl)-4,6-O-[(S)-phenylMethylene]-1-thio- | 87470-72-2 |
b-D-Galactopyranoside, phenyl 3,4,6-tris-O-(phenylMethyl)-1-thio- | b-D-Galactopyranoside, phenyl 3,4,6-tris-O-(phenylMethyl)-1-thio- | 183875-29-8 |
b-D-Galactopyranose, 1-deoxy-2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethylene)-1-(phenylsulfonyl)-, (S)- | b-D-Galactopyranose, 1-deoxy-2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethylene)-1-(phenylsulfonyl)-, (S)- | 124477-10-7 |
b-D-Gal, 2-(2-Carboxyethylthio)-ethyl | b-D-Gal, 2-(2-Carboxyethylthio)-ethyl | |
b-D-GalNAc, 2-(2-Carboxyethylthio)-ethyl | b-D-GalNAc, 2-(2-Carboxyethylthio)-ethyl | |
B-D-GALACTOSAMINE PENTAACETATE | B-D-GALACTOSAMINE PENTAACETATE | 12167-39-4 |
8-(b-D-Galactopyranose)-octanoicacid | 8-(b-D-Galactopyranose)-octanoicacid | |
B-D-GALACTOPYRANOSEPENTAACETATE | B-D-GALACTOPYRANOSEPENTAACETATE | |
BDG BROTH, HAJNA | BDG BROTH, HAJNA | |
B-D-FLUCOSE AZIDE | B-D-FLUCOSE AZIDE | |
BCPP protocol | BCPP protocol | |
Bcp1 protein | Bcp1 protein | |
BCP protocol | BCP protocol | |
2BC protein, poliovirus | 2BC protein, poliovirus | |
B2C protein | B2C protein | |
b-D-GlcNAc, 2-(2-Carboxyethylthio)-ethyl | b-D-GlcNAc, 2-(2-Carboxyethylthio)-ethyl | |
b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate | b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate | 99541-23-8 |
b-D-Glucopyranoside, ethyl 1-thio-, 2,3,4,6-tetrabenzoate | b-D-Glucopyranoside, ethyl 1-thio-, 2,3,4,6-tetrabenzoate | 113214-71-4 |
b-D-Glucopyranoside, ethyl 3-O-[(4-Methoxyphenyl)Methyl]-4,6-O-[(R)-phenylMethylene]-1-thio-, benzoate | b-D-Glucopyranoside, ethyl 3-O-[(4-Methoxyphenyl)Methyl]-4,6-O-[(R)-phenylMethylene]-1-thio-, benzoate | 151725-49-4 |
b-D-Glucopyranoside, 4-Methylphenyl 4,6-O-[(R)-(4-Methylphenyl)Methylene]-1-thio-, 2,3-dibenzoate | b-D-Glucopyranoside, 4-Methylphenyl 4,6-O-[(R)-(4-Methylphenyl)Methylene]-1-thio-, 2,3-dibenzoate | 922523-06-6 |
b-D-Glucopyranoside, 4-Methylphenyl 6-O-[(4-Methoxyphenyl)Methyl]-2,3-bis-O-(phenylMethyl)-1-thio- | b-D-Glucopyranoside, 4-Methylphenyl 6-O-[(4-Methoxyphenyl)Methyl]-2,3-bis-O-(phenylMethyl)-1-thio- | 582322-06-3 |
b-D-Glucopyranoside, phenyl 3,4,6-tris-O-(phenylMethyl)-1-thio- | b-D-Glucopyranoside, phenyl 3,4,6-tris-O-(phenylMethyl)-1-thio- | 130781-27-0 |
b-D-Glucopyranose, 1-[3-(3,4-dihydroxyphenyl)-2-propenoate] | b-D-Glucopyranose, 1-[3-(3,4-dihydroxyphenyl)-2-propenoate] | 14364-08-0 |
B-D-GLUCOSE 1-PHOSPHATE BIS(CYCLOHEXYLAM | B-D-GLUCOSE 1-PHOSPHATE BIS(CYCLOHEXYLAM | 14034-70-9 |
6-(B-D-GLUCOPYRANOSYL)-7-(B-D-GLUCOPYRANOSYLOXY)-5-HYDROXY-2-(P-HYDROXYPHENYL)-4-CHROMENONE | 6-(B-D-GLUCOPYRANOSYL)-7-(B-D-GLUCOPYRANOSYLOXY)-5-HYDROXY-2-(P-HYDROXYPHENYL)-4-CHROMENONE | |
B-D-GLUCOPYRANOSE | B-D-GLUCOPYRANOSE | 60976-49-0 |
2-(1-(B-D-GLUCOPYRANOSYLOXY)-1-METHYLETHYL)-2,3-DIHYDROFURO(3,2-G)CHROMEN-7-ONE | 2-(1-(B-D-GLUCOPYRANOSYLOXY)-1-METHYLETHYL)-2,3-DIHYDROFURO(3,2-G)CHROMEN-7-ONE | |
8-(B-D-GLUCOPYRANOSYL)-5,7-DIHYDROXY-2-(P-HYDROXYPHENYL)-4-CHROMENONE | 8-(B-D-GLUCOPYRANOSYL)-5,7-DIHYDROXY-2-(P-HYDROXYPHENYL)-4-CHROMENONE | |
b-D-Glucopyranosiduronic acid,(3b)-17-carboxy-28-norolean-12-en-3-yl | b-D-Glucopyranosiduronic acid,(3b)-17-carboxy-28-norolean-12-en-3-yl | 26020-14-4 |
(1-3,1-4)-b-D-glucan | (1-3,1-4)-b-D-glucan | |
(1-3,1-4)-b-D-glucan hydrolase | (1-3,1-4)-b-D-glucan hydrolase | |
B-D-Glucopyranoside,phenyl2,3-bis-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-1-thio- | B-D-Glucopyranoside,phenyl2,3-bis-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-1-thio- | 87470-70-0 |
B-D-Glucopyranoside,4-methylphenyl6-O-[(1,1-dimethylethyl)diphenylsilyl]-2,3-bis-O-(phenylmethyl)-1-thio- | B-D-Glucopyranoside,4-methylphenyl6-O-[(1,1-dimethylethyl)diphenylsilyl]-2,3-bis-O-(phenylmethyl)-1-thio- | 596087-20-6 |
B-D-Glucopyranose,1,6-anhydro-2-azido-2-deoxy-,3,4-diacetate | B-D-Glucopyranose,1,6-anhydro-2-azido-2-deoxy-,3,4-diacetate | 119005-80-0 |
BCR/CRM-061 AQUATIC PLANT | BCR/CRM-061 AQUATIC PLANT | |
BCR/CRM-150 SPIKED S MILK | BCR/CRM-150 SPIKED S MILK | |